Sayaka Kitanao

发表

A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study)

E. Araki, Norio Ishii, T. Matsumura, 2016, Journal of diabetes investigation.